Bafazol ІС 10 mg tablets blister, ,40
$16,78
Compound:
active ingredient: fabomotizol;
1 tablet contains fabomotizole dihydrochloride 10 mg;
other ingredients: potato starch, microcrystalline cellulose, StarLac® (lactose monohydrate, corn starch), talc, colloidal anhydrous silicon dioxide, magnesium stearate.
Dosage form. Pills.
Basic physical and chemical properties: tablets white or white with a creamy tint, flat-cylindrical in shape with a bevel; color inhomogeneity is allowed; on one surface of the tablet there is a trademark of the enterprise, on the second surface of the tablet there is a mark.
Pharmacotherapeutic group.
Drugs affecting the nervous system. Psycholeptic drugs. Anxiolytics. Other anxiolytics. Fabomotizol. ATX code N05B X04.
Indications.
The drug is indicated for use in adults for the treatment of anxiety conditions: generalized anxiety disorders, neurasthenia, adaptation disorders, patients with various somatic diseases (bronchial asthma, irritable bowel syndrome, systemic lupus erythematosus, coronary heart disease, arterial hypertension, arrhythmia, and other diseases
The drug is used to treat sleep disorders associated with anxiety; neurocirculatory dystonia, premenstrual syndrome, alcohol withdrawal syndrome to alleviate withdrawal symptoms when quitting smoking.
Contraindications.
Individual intolerance to any components of the drug. Galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome. During pregnancy and breastfeeding. Children under 18 years of age.
Method of administration and dose.
Use internally after meals.
The optimal single dose is 10 mg, the daily dose is 30 mg, which should be divided into 3 doses during the day. The duration of treatment is 2–4 weeks.
If necessary, on the recommendation of a doctor, the daily dose of the drug can be increased to 60 mg, and the duration of treatment to 3 months.
Package.
20 tablets in a blister; 2 or 3 blisters per pack.
Vacation category. Over the counter.
